RAP1BL
Ras-related protein Rap-1b-like protein
Also known as: RP1BL_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for RAP1BL in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
184 residues, UniProt reviewed canonical sequence.
>A6NIZ1|RAP1BL
1 MREYKLVVLG SRGVGKSALT VQFVQGIFVE KYDPTIEDSY REQVEVDAQQ CMLEILDTAG
61 TEQFTAMRDL YMKNGQGFAL VYSITAQSTF NDLQDLREQI LRVKDTDDVP MILVGNKCDL
121 EDERVVGKEQ GQNLARQWNN CAFLESSAKS KINVNEIFYD LVRQINRKTP VPGKARKKSS
181 CQLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RAP1BL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
OntologyGO
Biological processes
- cellular response to cAMP
- establishment of endothelial barrier
- negative regulation of synaptic vesicle exocytosis
- Rap protein signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RAP1BL as an antibody target. Whether an autoantibody or antibody against RAP1BL could matter depends on whether native RAP1BL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RAP1BL is annotated at the cell surface, where native RAP1BL is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RAP1BL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...